Wells Fargo & Company MN Sells 28,693 Shares of National Research Co. (NASDAQ:NRC)

Wells Fargo & Company MN decreased its position in National Research Co. (NASDAQ:NRC - Free Report) by 16.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 143,145 shares of the company's stock after selling 28,693 shares during the quarter. Wells Fargo & Company MN owned about 0.61% of National Research worth $2,525,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in NRC. ExodusPoint Capital Management LP raised its position in shares of National Research by 3.4% in the fourth quarter. ExodusPoint Capital Management LP now owns 21,035 shares of the company's stock valued at $371,000 after buying an additional 694 shares in the last quarter. Semanteon Capital Management LP raised its holdings in National Research by 9.9% in the 4th quarter. Semanteon Capital Management LP now owns 10,281 shares of the company's stock valued at $181,000 after acquiring an additional 929 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in National Research by 0.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 124,711 shares of the company's stock valued at $2,200,000 after acquiring an additional 970 shares in the last quarter. Principal Financial Group Inc. increased its position in shares of National Research by 10.7% in the fourth quarter. Principal Financial Group Inc. now owns 12,018 shares of the company's stock worth $212,000 after purchasing an additional 1,161 shares during the period. Finally, JPMorgan Chase & Co. grew its stake in National Research by 8.7% during the third quarter. JPMorgan Chase & Co. now owns 17,194 shares of the company's stock worth $393,000 after buying an additional 1,373 shares in the last quarter. Institutional investors own 47.26% of the company's stock.

National Research Price Performance

Shares of NASDAQ NRC traded down $0.51 during trading hours on Wednesday, hitting $11.36. 79,862 shares of the stock were exchanged, compared to its average volume of 94,443. The company's fifty day simple moving average is $13.03 and its two-hundred day simple moving average is $16.40. The company has a market cap of $260.67 million, a PE ratio of 10.82 and a beta of 0.41. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. National Research Co. has a 1-year low of $9.76 and a 1-year high of $35.81.

National Research (NASDAQ:NRC - Get Free Report) last posted its quarterly earnings results on Monday, April 28th. The company reported $0.25 EPS for the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%. The company had revenue of $33.55 million during the quarter.

National Research Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be given a $0.12 dividend. The ex-dividend date is Friday, June 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.23%. National Research's dividend payout ratio (DPR) is currently 45.71%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.